Document:

mulroyamendedandrestated

    ANAPTYSBIO, INC.  AMENDED AND RESTATED EMPLOYMENT AGREEMENT  This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made  effective from July 15, 2020 (the “Effective Date”) by and among ANAPTYSBIO, INC. (the “Company”)  and Dennis Mulroy (“CFO”).  The Company and CFO are hereinafter collectively referred to as the  “Parties,” and individually referred to as a “Party.”  This Agreement amends and restates in its entirety that  certain Employment Agreement between CFO and the Company dated July 13, 2020 (the “Prior  Agreement”).  RECITAL  The Company desires to employ CFO, and CFO is willing to accept such employment by Company,  on the terms and subject to the conditions set forth in this Agreement.  AGREEMENT  In consideration of the foregoing Recitals and the mutual promises and covenants herein contained,  and for other good and valuable consideration, the Parties, intending to be legally bound, agree as follows:  1. EMPLOYMENT.  1.1 Title.  Effective as of the Effective Date, CFO’s position shall be Chief Financial  Officer of the Company, subject to the terms and conditions set forth in this Agreement.  1.2 Term.  The term of this Agreement shall begin on the Effective Date and shall  continue until it is terminated pursuant to Section 4 herein (the “Term”).  1.3 Duties.  CFO shall do and perform all services, acts or things necessary or  advisable to manage and conduct the business of the Company and that are normally associated with the  position of Chief Financial Officer of the Company.  CFO shall report to the Chief Executive Officer.  1.4 Policies and Practices.  The employment relationship between the Parties shall be  governed by this Agreement and by the policies and practices established by the Company and/or the  Company’s Board of Directors (the “Board”), or any designated committee thereof.  In the event that the  terms of this Agreement differ from or are in conflict with the Company’s policies or practices or the  Company’s Employee Handbook, this Agreement shall control.  1.5 Location.  Unless the Parties otherwise agree in writing, and except as provided  in this Section 1.5, during the Term CFO shall perform the services CFO is required to perform pursuant to  this Agreement at the Company’s offices in San Diego, California; provided, however, that the Company  may from time to time require CFO to travel temporarily to other locations in connection with the  Company’s business; provided, further, upon the Effective Date, and until applicable government COVID- 19 quarantine restrictions applicable to the San Diego office are lifted and the San Diego office reopens,  the Company will allow CFO to perform the services remotely from CFO’s home.  2. LOYALTY; NONCOMPETITION; NONSOLICITATION.  2.1 Loyalty.  During CFO’s employment with the Company, CFO shall devote CFO’s  full business energies, interest, abilities and productive time to the proper and efficient performance of  CFO’s duties under this Agreement.  

 

  2  2.2 Agreement not to Participate in Company’s Competitors.  During CFO’s  employment with the Company, CFO agrees not to acquire, assume or participate in, directly or indirectly,  any position, investment or interest known by CFO to be adverse or antagonistic to the Company, its  business, or prospects, financial or otherwise, or in any company, person, or entity that is, directly or  indirectly, in competition with the business of the Company or any of its Affiliates (as defined below).   Ownership by CFO, in professionally managed funds over which CFO does not have control or discretion  in investment decisions, or as a passive investment, of less than two percent (2%) of the outstanding shares  of capital stock of any corporation with one or more classes of its capital stock listed on a national securities  exchange or publicly traded on a national securities exchange or in the over-the-counter market shall not  constitute a breach of this Section.  For purposes of this Agreement, “Affiliate,” means, with respect to any  specific entity, any other entity that, directly or indirectly, through one or more intermediaries, controls, is  controlled by or is under common control with such specified entity.  2.3 Covenant not to Compete.  During CFO’s employment with the Company, CFO  shall not engage in competition with the Company and/or any of its Affiliates in any manner or capacity,  as adviser, principal, agent, Affiliate, promoter, partner, officer, director, employee, owner, co-owner,  consultant, in any phase of the business of developing, manufacturing and marketing of products or services  that directly compete with the products or services of the Company, except with the prior written consent  of the CEO.  CFO shall be entitled to request written consent of the CEO with respect to potential advisory  and/or director opportunities presented to CFO by a third party, which CFO believes in good faith will not  interfere or compete with the on-going business of the Company.  3. COMPENSATION OF CFO.  3.1 Base Salary.  The Company shall pay CFO a base salary at the annualized rate of  $400,000 (the “Base Salary”), less payroll deductions and all required withholdings, payable in regular  periodic installments in accordance with the Company’s normal payroll practices.  The Base Salary shall  be prorated for any partial year of employment on the basis of a 365-day fiscal year.  3.2 Discretionary Bonus.  At the sole discretion of the Board and the Chief Executive  Officer, promptly following each calendar year of employment CFO shall be eligible to receive a  discretionary cash bonus of up to 40% of CFO’s then-current base salary (the “Bonus”), based on CFO’s  achievement relative to certain performance goals (“Performance Goals”) to be established by the Chief  Executive Officer and/or the Board or the Compensation Committee of the Board (the “Committee”) in  writing in a manner reasonably consistent with the Company’s priorities.  The determination of whether  CFO has met the Performance Goals for any given year, and if so, the amount of any Bonus that will be  paid for such year (if any), shall be determined by the Board or the Committee and Chief Executive Officer  in their sole and absolute discretion.  In order to be eligible to earn or receive any Bonus, CFO must remain  employed by the Company through and including the date of payment of such Bonus.  For the first calendar  year of CFO’s employment with the Company, the Bonus payable shall be pro-rated in accordance with the  percentage of the calendar year that the CFO is an employee of the Company.  3.3 Stock Option.  As soon as practicable following the Effective Date, subject to the  approval of the Board or the Committee, CFO will be granted an option to purchase up to 90,600 shares of  the Company’s Common Stock (the “Base Option”) pursuant to the terms of the Company’s 2017 Equity  Incentive Plan, as amended from time to time (the “Plan”).  The Base Option shall be subject to vesting  such that, subject to CFO’s continued employment with the Company, 1/4 of the shares subject to the Base  Option shall vest as of the first anniversary of the Effective Date and l/48th of the shares subject to the Base  Option shall vest in equal monthly installments on the monthly anniversary of the Effective Date of each  month for the 36 months thereafter.  The exercise price per share of the Base Option will be equal to the  closing selling price as reported on the Nasdaq Stock Market on the date the Base Option is granted.  The  

 

  3  Base Option will be governed by the Plan and shall be granted pursuant to a separate stock option grant  notice and stock option agreement.  3.4 Expense Reimbursements.  The Company will reimburse CFO for all reasonable  business expenses CFO incurs in conducting his duties hereunder, pursuant to the Company’s usual expense  reimbursement policies; provided that CFO supplies the appropriate substantiation for such expenses no  later than the end of the calendar month following the month in which such expenses were incurred by  CFO.  3.5 Changes to Compensation.  CFO’s compensation will be reviewed annually and  may be changed from time to time in the Company’s sole discretion.  3.6 Employment Taxes.  All of CFO’s compensation shall be subject to customary  withholding taxes and any other employment taxes as are commonly required to be collected or withheld  by the Company, as determined by the Company.  3.7 Benefits.  CFO shall, in accordance with Company policy and the terms of the  applicable plan documents, be eligible to participate in benefits under any benefit plan or arrangement that  may be in effect from time to time and made available to the Company’s senior management employees.  3.8 Holidays and Vacation.  CFO shall be eligible for paid holiday and vacation time  in accordance with Company policy as in effect from time to time.   4. TERMINATION.  4.1 Termination by the Company.  CFO’s employment with the Company is at will  and may be terminated by the Company at any time and for any reason, or for no reason, including, but not  limited to, under the following conditions:  4.1.1 Termination by the Company for Cause.  The Company may terminate  CFO’s employment under this Agreement for Cause (as defined below) by delivery of written notice to  CFO.  Any notice of termination given pursuant to this section shall effect termination as of the date of the  notice, or as of such other date specified in the notice.  4.1.2 Termination by the Company without Cause.  The Company may  terminate CFO’s employment under this Agreement without Cause at any time and for any reason, or for  no reason.  Such termination shall be effective on the date CFO is so informed, or as otherwise specified  by the Company.  4.2 Termination by CFO.  CFO may terminate his employment with the Company at  any time and for any reason, or for no reason, upon thirty (30) days written notice to the Company.  4.3 Termination for Death or Disability.  CFO’s employment with the Company  shall automatically terminate effective upon the date of CFO’s death or Disability (as defined in the Plan).  4.4 Termination by Mutual Agreement of the Parties.  CFO’s employment with the  Company may be terminated at any time upon a mutual agreement in writing of the Parties.  Any such  termination of employment shall have the consequences specified in such agreement.  4.5 Compensation upon Termination.  

 

  4  4.5.1 Death or Disability.  If CFO’s employment is terminated by death or  Disability, the Company shall pay to CFO, or to CFO’s heirs, CFO’s accrued and unpaid base salary and  accrued and unused vacation benefits earned through the date of termination at the rate in effect at the time  of termination, less standard deductions and withholdings.  The Company shall thereafter have no further  obligations to CFO and/or CFO’s heirs under this Agreement, except as otherwise provided by law.  4.5.2 Termination for Cause.  If the Company terminates CFO’s employment  for Cause, then the Company shall pay CFO’s accrued and unpaid base salary and accrued and unused  vacation benefits earned through the date of termination, at the rate in effect at the time of termination, less  standard deductions and withholdings.  The Company shall thereafter have no further obligations to CFO  under this Agreement, except as otherwise provided by law.  4.5.3 Termination by Company without Cause or by CFO for Good Reason  Not In Connection with a Change in Control.  If the Company terminates CFO’s employment without  Cause or if CFO resigns his employment for Good Reason (as defined below), in either case at any time  other than upon the occurrence of, or within the 13 months immediately following, the effective date of a  Change in Control, the Company shall pay CFO’s accrued and unpaid base salary and accrued and unused  vacation benefits earned through the date of termination, at the rate in effect at the time of termination, less  standard deductions and withholdings.  In addition to the above, if CFO furnishes to the Company an  executed waiver and release of claims in the form attached hereto as Exhibit A (or in such other form as  may be specified by the Company) (the “Release”) within the time period specified therein, but in no event  later than 45 days following CFO’s termination, and if CFO allows such Release to become effective in  accordance with its terms, then (i) CFO shall be entitled to severance in the form of continuation of his base  salary, at the base salary rate equal to the greater of the rate in effect at the time of termination or the rate  immediately prior to the event giving rise to Good Reason (the “Severance Payments”), for a period of  nine (9) months following the termination date (the “Severance Period”), and (ii) if CFO timely elects  COBRA coverage, the Company will pay directly to the insurance provider the premium for COBRA  continuation coverage for CFO and CFO’s family during the Severance Period or until he obtains new  employment, whichever comes first (the “COBRA Coverage”); provided that, if the Company determines  that it cannot provide the COBRA Coverage without potentially violating applicable law or incurring  additional expense under applicable law (including, without limitation, Section 2716 of the Public Health  Service Act), the Company will provide CFO, in lieu thereof, taxable, continued installment payments equal  to the COBRA premium, payable on the last day of a given month, for 9 months (measured from the  termination date), which payments will be made regardless of whether CFO elects COBRA continuation  coverage (the “COBRA Bonus”).  Notwithstanding the foregoing, the number of months of COBRA Bonus  to be paid, in any case, shall be reduced by the number of months of COBRA Coverage previously paid by  the Company.  The Severance Payments will be subject to standard payroll deductions and withholdings  and will be made on the Company’s regular payroll cycle, provided, however, that any Severance Payments  otherwise scheduled to be made prior to the effective date of the Release shall accrue and be paid in the  first payroll period that follows such effective date, provided, further, that if the 45 day period to execute  the Release spans two calendar years, no Severance Payments will be made until the later calendar year.   The Company shall thereafter have no further obligations to CFO under this Agreement, except as otherwise  provided by law.  4.5.4 Termination by Company without Cause or by CFO for Good Reason  in Connection with a Change in Control.  If the Company terminates CFO’s employment without Cause  or if CFO resigns his employment for Good Reason, in either case upon the occurrence of, or within the 13  months immediately following, the effective date of a Change in Control, the Company shall pay CFO’s  accrued and unpaid base salary and accrued and unused vacation benefits earned through the date of  termination, at the rate in effect at the time of termination, less standard deductions and withholdings.  In  addition, if CFO furnishes to the Company an executed Release within the time period specified therein,  

 

  5  but in no event later than 45 days following CFO’s termination, and if CFO allows such Release to become  effective in accordance with its terms, then CFO shall be entitled to: (1) the Severance Payments and  COBRA payments described in Section 4.5.3 above; provided, however, that the Severance Payments and  COBRA payments shall be increased from 9 months to 12 months, (2) a lump-sum cash amount equal to  the Bonus plus an amount equal to the product of (A) the Bonus, calculated based upon actual achievement  of Performance Goals as determined by the Board, multiplied by (B) the quotient of (i) the number of days  elapsed in such fiscal year through the effective date of Executive’s termination divided by (ii) 365, and (3)  accelerated vesting of all of CFO’s unvested Company equity awards, such that CFO shall become vested  in 100% of the shares subject to all such equity awards on the effective date of the Release; provided,  however, that the vesting of any performance-based awards shall be as if all applicable performance criteria  were achieved at target levels.  The Company shall thereafter have no further obligations to CFO under this  Agreement, except as otherwise provided by law.  4.6 Definitions.  For purposes of this Agreement, the following terms shall have the  following meanings:  4.6.1 “Cause” shall mean the occurrence of any one or more of the following:  (i) CFO’s commission of any crime involving fraud, dishonesty or moral turpitude; (ii) CFO’s attempted  commission of or participation in a fraud or act of dishonesty against the Company that results in (or might  have reasonably resulted in) material harm to the business of the Company; (iii) CFO’s intentional, material  violation of any contract or agreement between CFO and the Company or any statutory duty CFO owes to  the Company; or (iv) CFO’s conduct that constitutes gross insubordination, incompetence or habitual  neglect of duties and that results in (or might have reasonably resulted in) material harm to the business of  the Company; provided, however, that the action or conduct described in clauses (iii) and (iv) above will  constitute “Cause” only if such action or conduct continues after the Company has provided CFO with  written notice thereof and thirty (30) days to cure, or otherwise remedy to the extent possible under direct  control of the CFO, the same.  An occurrence of “Cause” as set forth in the preceding sentence shall be  based upon a good faith determination by the Board.  CFO’s Disability shall not constitute Cause as set  forth herein.  The determination that a termination is for Cause shall be by the Board in its sole and exclusive  judgment and discretion.  4.6.2 “Change in Control” shall have the meaning set forth in the Amended and  Restated 2006 Equity Incentive Plan.  4.6.3 “Good Reason” shall mean any of the following actions: (i) the assignment  to CFO of any duties or responsibilities that results in a material diminution in CFO’s function as in effect  immediately prior to the effective date of the Change in Control; provided, however, that it will be  considered a material diminution in CFO’s function if, following a Change in Control, the CFO is not  reporting directly to the Chief Executive Officer who is in turn reporting to the Company’s (or if applicable  ultimate parent entity’s) corporate board of directors; (ii) a reduction by the Company in CFO’s annual base  salary as in effect on the effective date of the Change in Control; provided, however, that Good Reason  shall not be deemed to have occurred in the event of a reduction in CFO’s annual base salary that is pursuant  to a salary reduction program affecting substantially all of the employees of the Company and that does not  adversely affect CFO to a greater extent than other similarly situated employees; or (iii) a relocation of  CFO’s primary business office to a location more than 50 miles from the location of CFO’s primary  business office as of the effective date of the Change in Control, except for required travel by CFO on the  Company’s business to an extent substantially consistent with CFO’s business travel obligations prior to  the effective date of the Change in Control.  For the purposes of application of this definition of Good  Reason to Section 4.5.3, the words “as in effect immediately prior to the effective date of the Change in  Control” shall be read to mean as of, or immediately prior to, the date of the event giving rise to Good  Reason.  In all events, in order for a termination for Good Reason to occur, the CFO must provide the  

 

  6  Company with written notice of the condition constituting Good Reason within 90 days of the initial  occurrence of such condition, and allow the Company a 30-day cure period in which to cure such condition,  and the CFO must resign employment within 10 days of the end of such 30-day cure period if the Company  does not cure the condition in such cure period.  For clarity, “corporate board of directors” as used in the  definition of Good Reason means the Company’s (or if applicable ultimate parent entity’s) board of  directors as such term is used in Section 141 of the Delaware General Corporation Law, or if the Company  (or if applicable ultimate parent entity) is not a corporation organized under Delaware law, the most senior  governing body of the Company (or if applicable ultimate parent entity) the majority of which is comprised  of non-employee and independent members and has responsibility and authority for managing the business  and affairs of the Company (or if applicable ultimate parent entity).  4.7 Survival of Certain Sections.  Sections 3.4, 3.6 and 4 through 18 of this  Agreement will survive the termination of this Agreement.  4.8 Parachute Payment.  If any payment or benefit CFO would receive pursuant to  this Agreement (“Payment”) would (i) constitute a “Parachute Payment” within the meaning of Section  280G of the Internal Revenue Code of 1986, as amended (the “Code”), and (ii) but for this sentence, be  subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall  be equal to the Reduced Amount.  The “Reduced Amount” shall be either (x) the largest portion of the  Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest  portion, up to and including the total of the Payment, whichever amount, after taking into account all  applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the  highest applicable marginal rate), results in CFO’s receipt, on an after-tax basis, of the greatest economic  benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a  reduction in payments or benefits constituting Parachute Payments is necessary so that the Payment equals  the Reduced Amount, reduction shall occur in the manner that results in the greatest economic benefit for  CFO.  If more than one method of reduction will result in the same economic benefit, the items so reduced  will be reduced pro rata.  In the event it is subsequently determined by the Internal Revenue Service that some portion of the  Reduced Amount (as determined pursuant to clause (x) in the preceding paragraph) is subject to the Excise  Tax, CFO agrees to promptly return to the Company a sufficient amount of the Payment so that no portion  of the Reduced Amount is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount is  determined in accordance with clause (y) in the preceding paragraph, CFO will have no obligation to return  any portion of the Payment pursuant to the preceding sentence.  Unless CFO and the Company agree on an alternative accounting or law firm, the accounting firm  then engaged by the Company for general tax compliance purposes shall perform the foregoing calculations.   If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual,  entity or group effecting the Change in Control, the Company shall appoint a nationally recognized  accounting, law or consulting firm to make the determinations required hereunder.  The Company shall  bear all expenses with respect to the determinations by such accounting, law or consulting firm required to  be made hereunder.  The Company shall use commercially reasonable efforts such that the accounting, law or consulting  firm engaged to make the determinations hereunder shall provide its calculations, together with detailed  supporting documentation, to CFO and the Company within 15 calendar days after the date on which CFO’s  right to a Payment is triggered (if requested at that time by CFO or the Company) or such other time as  requested by CFO or the Company.  

 

  7  4.9 Application of Internal Revenue Code Section 409A.  Notwithstanding anything  to the contrary set forth herein, any payments and benefits provided under this Agreement (the “Severance  Benefits”) that constitute “deferred compensation” within the meaning of Section 409A of the Code and  the regulations and other guidance thereunder and any state law of similar effect (collectively “Section  409A”) shall not commence in connection with CFO’s termination of employment unless and until CFO  has also incurred a “separation from service” (as such term is defined in Treasury Regulation Section  1.409A-1(h)) (“Separation From Service”), unless the Company reasonably determines that such amounts  may be provided to CFO without causing CFO to incur the additional 20% tax under Section 409A.   It is intended that each installment of the Severance Benefits payments provided for in this  Agreement is a separate “payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i).  For  the avoidance of doubt, it is intended that payments of the Severance Benefits set forth in this Agreement  satisfy, to the greatest extent possible, the exemptions from the application of Section 409A provided under  Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9).  However, if the  Company (or, if applicable, the successor entity thereto) determines that the Severance Benefits constitute  “deferred compensation” under Section 409A and CFO is, on the termination of service, a “specified  employee” of the Company or any successor entity thereto, as such term is defined in Section  409A(a)(2)(B)(i) of the Code, then, solely to the extent necessary to avoid the incurrence of the adverse  personal tax consequences under Section 409A, the timing of the Severance Benefit payments shall be  delayed until the earlier to occur of: (i) the date that is six months and one day after CFO’s Separation From  Service, or (ii) the date of CFO’s death (such applicable date, the “Specified Employee Initial Payment  Date”), the Company (or the successor entity thereto, as applicable) shall (A) pay to CFO a lump sum  amount equal to the sum of the Severance Benefit payments that CFO would otherwise have received  through the Specified Employee Initial Payment Date if the commencement of the payment of the  Severance Benefits had not been so delayed pursuant to this Section and (B) commence paying the balance  of the Severance Benefits in accordance with the applicable payment schedules set forth in this Agreement.  Notwithstanding anything to the contrary set forth herein, CFO shall receive the Severance Benefits  described above, if and only if CFO duly executes and returns to the Company within the applicable time  period set forth therein, but in no event more than forty-five days following Separation From Service, the  Release and permits the Release to become effective in accordance with its terms.  Notwithstanding any  other payment schedule set forth in this Agreement, none of the Severance Benefits will be paid or otherwise  delivered prior to the effective date of the Release.  Except to the extent that payments may be delayed until  the Specified Employee Initial Payment Date pursuant to the preceding paragraph, on the first regular  payroll pay day following the effective date of the Release, the Company will pay CFO the Severance  Benefits that CFO would otherwise have received under the Agreement on or prior to such date but for the  delay in payment related to the effectiveness of the Release, with the balance of the Severance Benefits  being paid as originally scheduled.  All amounts payable under the Agreement will be subject to standard  payroll taxes and deductions.  5. CONFIDENTIAL AND PROPRIETARY INFORMATION.  CFO has already executed, as a  condition of CFO’s employment with the Company, the Company’s standard form of Proprietary  Information and Inventions Agreement (the “PIIA”).  The PIIA remains in full force and effect.  6. ASSIGNMENT AND BINDING EFFECT.  This Agreement shall be binding upon and inure to the benefit of CFO and CFO’s heirs, executors,  personal representatives, assigns, administrators and legal representatives.  Because of the unique and  personal nature of CFO’s duties under this Agreement, neither this Agreement nor any rights or obligations  under this Agreement shall be assignable by CFO.  This Agreement shall be binding upon and inure to the  benefit of the Company and its successors, assigns and legal representatives.  Any such successor of the  

 

  8  Company will be deemed substituted for the Company under the terms of this Agreement for all purposes.   For this purpose, “successor” means any person, firm, corporation or other business entity which at any  time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the  assets or business of the Company.   7. NOTICES.  All notices or demands of any kind required or permitted to be given by the Company or CFO  under this Agreement shall be given in writing and shall be personally delivered (and receipted for) or faxed  during normal business hours or mailed by certified mail, return receipt requested, postage prepaid,  addressed as follows:  If to the Company:  10770 Wateridge Circle, Suite 210  San Diego, CA 92121  Attention: Chief Executive Officer  If to CFO:  Dennis Mulroy  4370 Mensha Place  San Diego, CA 92130  Any such written notice shall be deemed given on the earlier of the date on which such notice is personally  delivered or three days after its deposit in the United States mail as specified above.  Either Party may  change its address for notices by giving notice to the other Party in the manner specified in this Section.  8. CHOICE OF LAW.  This Agreement shall be construed and interpreted in accordance with the internal laws of the State  of California without regard to its conflict of laws principles.  9. INTEGRATION.  This Agreement, including Exhibit A and the PIIA, contains the complete, final and exclusive  agreement of the Parties relating to the terms and conditions of CFO’s employment and the termination of  CFO’s employment, and supersedes any and all prior and/or contemporaneous oral and written employment  agreements or arrangements between the Parties, including the Prior Agreement, which is hereby  terminated.  By signing below, CFO acknowledges that he has been paid all compensation and benefits  owed to him by the Company and that the Company has fully performed all of its obligations under the  Prior Agreement.  10. AMENDMENT.  This Agreement cannot be amended or modified except by a written agreement signed by CFO and  the Company.  11. WAIVER.  

 

  9  No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived,  except with the written consent of the Party against whom the wavier is claimed, and any waiver or any  such term, covenant, condition or breach shall not be deemed to be a waiver of any preceding or succeeding  breach of the same or any other term, covenant, condition or breach.  12. SEVERABILITY.  The finding by a court of competent jurisdiction of the unenforceability, invalidity or illegality of  any provision of this Agreement shall not render any other provision of this Agreement unenforceable,  invalid or illegal.  Such court shall have the authority to modify or replace the invalid or unenforceable term  or provision with a valid and enforceable term or provision, which most accurately represents the Parties’  intention with respect to the invalid or unenforceable term, or provision.  13. INTERPRETATION; CONSTRUCTION.  The headings set forth in this Agreement are for convenience of reference only and shall not be  used in interpreting this Agreement.  This Agreement has been drafted by legal counsel representing the  Company, but CFO has been encouraged to consult with, and has consulted with, CFO’s own independent  counsel and tax advisors with respect to the terms of this Agreement.  The Parties acknowledge that each  Party and its counsel has reviewed and revised, or had an opportunity to review and revise, this Agreement,  and any rule of construction to the effect that any ambiguities are to be resolved against the drafting party  shall not be employed in the interpretation of this Agreement.  14. REPRESENTATIONS AND WARRANTIES.  CFO represents and warrants that CFO is not restricted or prohibited, contractually or otherwise,  from entering into and performing each of the terms and covenants contained in this Agreement, and that  CFO’s execution and performance of this Agreement will not violate or breach any other agreements  between CFO and any other person or entity.  15. COUNTERPARTS.  This Agreement may be executed in two counterparts, each of which shall be deemed an original,  all of which together shall contribute one and the same instrument.  16. ARBITRATION.  To ensure the rapid and economical resolution of disputes that may arise in connection with CFO’s  employment with the Company, CFO and the Company agree that any and all disputes, claims, or causes  of action, in law or equity, arising from or relating to CFO’s employment, or the termination of that  employment, will be resolved, to the fullest extent permitted by law, by final, binding and confidential  arbitration pursuant to both the substantive and procedural provisions of the Federal Arbitration Act in San  Diego, California conducted by the Judicial Arbitration and Mediation Services/Endispute, Inc. (“JAMS”),  or its successors, under the then current rules of JAMS for employment disputes; provided that the arbitrator  shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award  such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including  the arbitrator’s essential findings and conclusions and a statement of the award.  Accordingly, CFO and the  Company hereby waive any right to a jury trial.  Both CFO and the Company shall be entitled to all rights  and remedies that either CFO or the Company would be entitled to pursue in a court of law.  The Company  shall pay any JAMS filing fee and shall pay the arbitrator’s fee.  Nothing in this Agreement is intended to  prevent either CFO or the Company from obtaining injunctive relief in court to prevent irreparable harm  

 

  10  pending the conclusion of any such arbitration.  Notwithstanding the foregoing, CFO and the Company  each have the right to resolve any issue or dispute involving confidential, proprietary or trade secret  information, or intellectual property rights, by Court action instead of arbitration.   17. TRADE SECRETS OF OTHERS.  It is the understanding of both the Company and CFO that CFO shall not divulge to the Company  and/or its subsidiaries any confidential information or trade secrets belonging to others, including CFO’s  former employers, nor shall the Company and/or its Affiliates seek to elicit from CFO any such information.   Consistent with the foregoing, CFO shall not provide to the Company and/or its Affiliates, and the Company  and/or its Affiliates shall not request, any documents or copies of documents containing such information.  18. ADVERTISING WAIVER.  CFO agrees to permit the Company, and persons or other organizations authorized by the Company,  to use, publish and distribute advertising or sales promotional literature concerning the products and/or  services of the Company, or the machinery and equipment used in the provision thereof, in which CFO’s  name and/or pictures of CFO taken in the course of CFO’s provision of services to the Company appear.   CFO hereby waives and releases any claim or right CFO may otherwise have arising out of such use,  publication or distribution.  [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]    

 

  [SIGNATURE PAGE TO EMPLOYMENT AGREEMENT]  IN WITNESS WHEREOF, the Parties have executed the Agreement as of the date below.  ANAPTYSBIO, INC.  By: /s/Dan Faga     Name:  Dan Faga  Title: Interim President & CEO  Dated: April 29, 2022     CFO:  /s/Dennis Mulroy     DENNIS MULROY  Dated: April 29, 2022       

 

    EXHIBIT A  RELEASE AND WAIVER OF CLAIMS  TO BE SIGNED ON OR FOLLOWING THE SEPARATION DATE ONLY  In consideration of the payments and other benefits set forth in the Employment Agreement  effective July 15, 2020, to which this form is attached, I, Dennis Mulroy, hereby furnish AnaptysBio, Inc.  (the “Company”), with the following release and waiver (“Release and Waiver”).  In exchange for the consideration provided to me by the Employment Agreement that I am not  otherwise entitled to receive, I hereby generally and completely release the Company and its current and  former directors, officers, employees, stockholders, partners, agents, attorneys, predecessors, successors,  parent and subsidiary entities, insurers, affiliates, and assigns (collectively, the “Released Parties”) from  any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way  related to events, acts, conduct, or omissions occurring prior to or on the date that I sign this Agreement  (collectively, the “Released Claims”).  The Released Claims include, but are not limited to: (a) all claims  arising out of or in any way related to my employment with the Company, or the termination of that  employment; (b) all claims related to my compensation or benefits from the Company including salary,  bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock  options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful  termination, and breach of the implied covenant of good faith and fair dealing; (d) all tort claims, including  claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all  federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation,  misclassification, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as  amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in  Employment Act of 1967 (as amended) (the “ADEA”), the California Labor Code, and the California Fair  Employment and Housing Act (as amended).  Notwithstanding the foregoing, the following are not included  in the Released Claims (the “Excluded Claims”): (a) any rights or claims for indemnification I may have  pursuant to the charter or bylaws of the Company or under applicable law; (b) any rights or claims to  unemployment compensation, funds accrued in my 401k account, or any vested equity incentives; (c) any  rights that are not waivable as a matter of law; or (d) any claims arising from the breach of this Agreement.   I hereby represent and warrant that, other than the Excluded Claims, I am not aware of any claims I have  or might have against any of the Released Parties that are not included in the Released Claims.  I also acknowledge that I have read and understand Section 1542 of the California Civil Code which  reads as follows: “A general release does not extend to claims which the creditor does not know or  suspect to exist in his or her favor at the time of executing the release, which if known by him or her  must have materially affected his or her settlement with the debtor.” I hereby expressly waive and  relinquish all rights and benefits under that Section and any law of any jurisdiction, including New York,  of similar effect with respect to any claims I may have against the Company.  I acknowledge that, among other rights, I am waiving and releasing any rights I may have under  ADEA, that this Release and Waiver is knowing and voluntary, and that the consideration given for this  Release and Waiver is in addition to anything of value to which I was already entitled as an executive of  the Company.  I further acknowledge that I have been advised, as required by the Older Workers Benefit  Protection Act, that: (a) the release and waiver granted herein does not relate to claims under the ADEA  which may arise after this Release and Waiver is executed; (b) I should consult with an attorney prior to  executing this Release and Waiver; and (c) if I am age 40 or older at the time of execution of this release, I  have 21 days from the date of termination of my employment with the Company in which to consider this  Release and Waiver (although I may choose voluntarily to execute this Release and Waiver earlier); and  

 

    (d) if I am age 40 or older at the time of execution of this release, I have seven days following the execution  of this Release and Waiver to revoke my consent to this Release and Waiver and this Release and Waiver  shall not be effective until the seven day revocation period has expired without my having previously  revoked this Release and Waiver.   I agree not to disparage the Company and its officers, directors, employees, shareholders and/or  agents, in any manner likely to be harmful to them or their business, business reputations or personal  reputations; provided that I may respond accurately and fully to any question, inquiry or request for  information when required by legal process (e.g., a valid subpoena or other similar compulsion of law) or  as part of a government investigation.   I acknowledge my continuing obligations under my Proprietary Information and Inventions  Agreement.  Pursuant to the Proprietary Information and Inventions Agreement I understand that among  other things, I must not use or disclose any confidential or proprietary information of the Company and I  must immediately return all Company property and documents (including all embodiments of proprietary  information) and all copies thereof in my possession or control.  I understand and agree that my right to the  severance pay I am receiving in exchange for my agreement to the terms of this Release and Waiver is  contingent upon my continued compliance with my Proprietary Information and Inventions Agreement.   This Release and Waiver constitutes the complete, final and exclusive embodiment of the entire  agreement between the Company and me with regard to the subject matter hereof.  I am not relying on any  promise or representation by the Company that is not expressly stated herein.  This Release and Waiver  may only be modified by a writing signed by both me and a duly authorized officer of the Company.  Date:   By:     DENNIS MULROYExhibit
10.2

 

THIS
PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE
THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH
REGISTRATION IS NOT REQUIRED.  

 

PROMISSORY NOTE

 

	Principal Amount: Up to $800,000	Issuance Date: April [ ], 2021

 

Hudson
Acquisition I Corp., a Delaware corporation and blank check company (the “Maker”), promises to pay to the order
of Hudson SPAC Holding, LLC or its registered assigns or successors in interest (the
“Payee”), the principal sum of up to Eight Hundred Thousand Dollars ($800,000) (the “Principal Amount”)
in lawful money of the United States of America, on the terms and conditions described below. All payments on this Note shall be
made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may
from time to time designate by written notice in accordance with the provisions of this Note.

 

1. Principal. The
principal balance of this Note shall be payable by the Maker on the earlier of: (i) June 30, 2023, or (ii) the date on which Maker consummates
an initial business combination. The principal balance may be prepaid at any time. The principal balance shall be payable by the
Maker either: (i) in cash, or (ii) in shares of Maker’s common stock (“Conversion Shares”), par value $0.0001,
at the Payee’s election in writing. Payee may elect to convert any outstanding principal balance into Conversion Shares, at any
time when this Note remains outstanding, at a fixed conversion price of $10.00 per share. Under no circumstances shall any individual,
including but not limited to any officer, director, employee or shareholder of the Maker, be personally obligated for any obligations
or liabilities of the Maker hereunder.

 

2. Interest. No
interest, other than the imputed interest charged by the appropriate government authority, shall accrue on the unpaid principal balance
of this Note.

 

Maker
and Payee agree that Maker may request up to the Principal Amount for costs reasonably related to Maker’s business dealings and
operations. The Note may be drawn down from time to time prior to the earlier of: (i) June 30, 2023, or (ii) the date on which Maker consummates
an initial business combination, upon written request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown
Request must state the amount to be drawn down, and must not be an amount less than One Thousand Dollars ($1,000) unless agreed upon by
Maker and Payee. Payee shall fund each Drawdown Request no later than five (5) business days after receipt of a Drawdown Request; provided,
however, that the maximum amount of drawdowns collectively under this Note is Eight Hundred Thousand Dollars ($800,000). Once an amount
is drawn down under this Note, it shall not be available for future Drawdown Requests even if prepaid. No fees, payments or other amounts
shall be due to Payee in connection with, or as a result of, any Drawdown Request by Maker. Notwithstanding the foregoing, all payments
shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation)
reasonable attorneys’, auditor’s, or bookkeeper’s fees associated with the Maker’s initial public offering of
its securities, and then to the reduction of the unpaid principal balance of this Note.

 

     

     

    

 

3. Application
of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under
this Note, including (without limitation) reasonable attorneys’, auditor’s, or bookkeeper’s fees associated with the
Maker’s initial public offering of its securities, then to the payment in full of any late charges and finally to the reduction
of the unpaid principal balance of this Note.

 

4. Events
of Default. The following shall constitute an event of default (“Event of Default”):

 

(a)  Failure
to Make Required Payments. Failure by Maker to pay the Principal Amount due pursuant to this Note within five (5) business days of
the date specified above.

 

(b) Voluntary
Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation
or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian,
sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for
the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action
by Maker in furtherance of any of the foregoing. 

 

(c)  Involuntary
Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an
involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian,
trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation
of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

  

5. Remedies.

 

(a)  Upon
the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be
due immediately and payable, whereupon the unpaid Principal Amount of this Note, and all other amounts payable hereunder, shall become
immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived,
anything contained herein or in the documents evidencing the same to the contrary notwithstanding. 

 

(b)  Upon
the occurrence of an Event of Default specified in Sections 5(b) and 5(c), the unpaid principal balance of this Note, and all other sums
payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part
of Payee.

 

6. Waivers. Maker
and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and
notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms
of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal,
or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for
any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may
be levied upon pursuant to a judgment obtained by virtue hereof or any writ of execution issued hereon, may be sold upon any such writ
in whole or in part in any order desired by Payee.

 

    2

     

    

 

7. Unconditional
Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement
of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party,
and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to
by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect
to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties
hereto without notice to Maker or affecting Maker’s liability hereunder.

 

8. Notices. All
notices, statements or other documents which are required or contemplated by this Note shall be made in writing and delivered: (i) personally
or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address
designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may
be designated in writing by such party or (iii) by electronic mail, to the electronic mail address most recently provided to such party
or such other electronic mail address as may be designated in writing by such party. Any notice or other communication so transmitted
shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation,
if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days
after mailing if sent by mail.

 

9. Construction. THIS
NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF DELAWARE, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

 

10. Severability. Any
provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective
to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 

 

11. Trust
Waiver.  Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or
claim of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the proceeds
of the initial public offering (the “IPO”) to be conducted by the Maker (including the deferred underwriters discounts
and commissions) and the proceeds of the sale of the units to be issued in a private placement to occur prior to the closing of the IPO
are to be deposited, as described in greater detail in the registration statement and prospectus to be filed with the Securities and Exchange
Commission in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against
the trust account for any reason whatsoever.

 

12. Amendment;
Waiver.  Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of
the Maker and the Payee.

 

13. Assignment.
No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or
otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall
be void.

 

[Signature page follows]

 

    3

     

    

 

IN
WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the
day and year first above written.

 

	Hudson Acquisition I Corp.  	 
	 	 	 
	By:	/s/  	 
	 	Name:  Jiang Hui	 
	 	Title: Chief Executive Officer	 

 

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]